Cellectis SA (LTS:0WA2)
€ 1.897 -0.02 (-1.04%) Market Cap: 188.58 Mil Enterprise Value: 137.41 Mil PE Ratio: 0 PB Ratio: 1.62 GF Score: 55/100

Cellectis SA at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript

Sep 17, 2020 / 08:55AM GMT
Release Date Price: €17.1 (-0.23%)
Operator

This presentation is for Bank of America clients only. If you are a member of the media or the press, please disconnect now.

Peter Smith;AndrÃ;Choulika
BofA Merrill Lynch, Research Division - Research Analyst;

Okay. Good morning, and thank you very much for joining us this morning. For those of you who don't know me, my name is Peter Smith, and I'm an associate on the EU pharma team here at Bank of America. And it's my pleasure to welcome André Choulika from Cellectis, Chairman and CEO. And thank you very much for joining me, particularly, as it's so early in the morning over there.

And just as a reminder, for people listening in, if you have any questions you'd like me to ask, please submit them via the Veracast app, or if there are any technical issues with this, please feel free to email me at [email protected].

And with that, I'm going to hand over to André, who's going to give a presentation to kick us off, and then we'll jump into Q&A and fire side chat. So over to you, André.

©

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot